https://wiki.tiffa.net/w/index.php?action=history&feed=atom&title=Translations%3ASodium%2Fglucose_cotransporter_2%2F4%2FenTranslations:Sodium/glucose cotransporter 2/4/en - Revision history2026-07-04T09:39:07ZRevision history for this page on the wikiMediaWiki 1.43.0https://wiki.tiffa.net/w/index.php?title=Translations:Sodium/glucose_cotransporter_2/4/en&diff=116848&oldid=prevFuzzyBot: Importing a new version from external source2024-02-18T10:48:29Z<p>Importing a new version from external source</p>
<p><b>New page</b></p><div>== SGLT2 inhibitors for diabetes ==<br />
{{Main|SGLT2 inhibitor}}<br />
[[SGLT2 inhibitor]]s are also called gliflozins or flozins. They lead to a reduction in blood glucose levels, and therefore have potential use in the treatment of [[type 2 diabetes]]. Gliflozins enhance glycemic control as well as reduce [[Human body weight|body weight]] and systolic and diastolic [[blood pressure]]. The gliflozins canagliflozin, dapagliflozin, and empagliflozin may lead to euglycemic [[ketoacidosis]]. Other side effects of gliflozins include increased risk of Fournier gangrene</div>FuzzyBot